- Home
- WNEB vs LYEL Comparison
WNEB vs LYEL Comparison
Compare WNEB & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNEB
- LYEL
- Stock Information
- Founded
- WNEB 1853
- LYEL 2018
- Country
- WNEB United States
- LYEL United States
- Employees
- WNEB N/A
- LYEL N/A
- Industry
- WNEB Savings Institutions
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- WNEB Finance
- LYEL Health Care
- Exchange
- WNEB Nasdaq
- LYEL Nasdaq
- Market Cap
- WNEB 195.7M
- LYEL 207.7M
- IPO Year
- WNEB N/A
- LYEL 2021
- Fundamental
- Price
- WNEB $11.44
- LYEL $10.23
- Analyst Decision
- WNEB Buy
- LYEL Sell
- Analyst Count
- WNEB 2
- LYEL 2
- Target Price
- WNEB $11.00
- LYEL $15.00
- AVG Volume (30 Days)
- WNEB 97.2K
- LYEL 70.4K
- Earning Date
- WNEB 07-22-2025
- LYEL 08-19-2025
- Dividend Yield
- WNEB 2.53%
- LYEL N/A
- EPS Growth
- WNEB N/A
- LYEL N/A
- EPS
- WNEB 0.59
- LYEL N/A
- Revenue
- WNEB $76,036,000.00
- LYEL $65,000.00
- Revenue This Year
- WNEB N/A
- LYEL N/A
- Revenue Next Year
- WNEB $7.36
- LYEL N/A
- P/E Ratio
- WNEB $18.78
- LYEL N/A
- Revenue Growth
- WNEB 2.15
- LYEL N/A
- 52 Week Low
- WNEB $7.42
- LYEL $7.65
- 52 Week High
- WNEB $11.68
- LYEL $32.40
- Technical
- Relative Strength Index (RSI)
- WNEB 65.12
- LYEL 45.43
- Support Level
- WNEB $10.94
- LYEL $10.01
- Resistance Level
- WNEB $11.41
- LYEL $12.00
- Average True Range (ATR)
- WNEB 0.29
- LYEL 1.01
- MACD
- WNEB -0.01
- LYEL -0.20
- Stochastic Oscillator
- WNEB 90.24
- LYEL 3.35
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.